Commission on Novel Technology in CNVs

August 4, 2020

Dup15q Alliance is proud to be a founding organization for the Commission on Novel Technology in Neurodevelopmental Copy Number Variants (CNVs)

Knowing there needs to be new technology to support genetic disorders with multiple copy numbers and large anomalies. Dup15q Alliance teamed up with Project 8P and Ring 14 (both rare disorders with large chromosome anomalies) to develop the Commission for Neurodevelopmental CNV’s The commission aims to investigate the challenges common to neurodevelopmental disorders involving copy number changes (duplications or deletions) involving multiple genes in order to accelerate therapeutic developments.

Mission:
To establish a Commission that is a patient-driven collaborative group of stakeholders to advance novel technologies to treat neurodevelopmental diseases with large chromosome anomalies.